Scientists at UC San Francisco have developed a powerful new cancer therapy that remains inactive until it reaches the brain, where it switches on to attack deadly tumors. The engineered immune cells, called B-SYNC CAR-T cells, completely eliminated diffuse midline glioma (DMG), an aggressive childhood brain cancer that is almost always fatal within a year, in two mouse models.
More in Research
A little-known protein could be a major culprit in type 2 diabetes
November 9, 2026
Hidden climate superpower: Why some ocean “snow” carries six times more carbon
November 9, 2026
Scientists discover stunning new Amazon fish that may already be endangered
November 8, 2026
An ancient ocean full of giant predators reveals a surprising twist in evolution
November 8, 2026
Einstein's equations reveal how gravity could break, reconnect, and release energy
November 8, 2026
A 24-hour fast triggers a surprising repair response in the gut
November 8, 2026
Latest News
How yesterday's waste is becoming tomorrow's fashion
November 9, 2026
Charity wants bee, bird and butterfly population boost
November 9, 2026
Analysis | Politics Of Drugs: BJP Looks To Turn Punjab AAP's Biggest Challenge Into Electoral Gains
November 9, 2026
Armed Forces Medical Services Recruitment 2026: Apply For 120 Medical Officer Posts
November 9, 2026
6 Of Family Killed After Fire At Goldsmith's House In Madhya Pradesh's Seoni
November 9, 2026
அனிருத் திருமணம்.. க்ரீஸ் நாட்டுக்கு சென்ற ஸ்டாலின், உதயநிதி.. கொண்டாட்டம் ஆரம்பம்
November 9, 2026